Menin-MLL inhibitors reverse oncogenic activity of MLL fusion proteins in leukemia.
Grembecka J; He S; Shi A; Purohit T; Muntean AG; Sorenson RJ; Showalter HD; Murai MJ; Belcher AM; Hartley T; Hess JL; Cierpicki T; Nature Chemical Biology, 2012, vol. 8, issue 3, p 277, ISSN 15524469. ISBN 15524469.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef